Skip to content
Search

Latest Stories

Pharmacist brothers offer ‘Jabs with Kebabs’ to encourage Covid vaccine uptake

A pair of pharmacist brothers, who also own a popular restaurant in Kent, have started an innovative initiative ‘Jabs with Kebabs’ to encourage their community in England to come forward and take their Covid-19 vaccines.

Rav and Raj Chopra, who own V’s Punjabi Grill, an Indian restaurant in Gravesend, established the walk-in vaccine site after their father, Jagtar Chopra, became unwell with Covid-19 last year.


The duo is among thousands to volunteer for the National Health Service (NHS) vaccine programme.

Talking to the PA news agency, Raj said he was inspired by the experience of his father, who got infected with the virus and has fully recovered since then.

“From a personal point of view, it was very debilitating to see Dad like that,” said Raj Chopra. “It got everyone’s emotions in play.

“To see it hit home so close to our hearts, it was a very tough pill – pardon the pun – to take. However, every cloud has a silver lining and it’s inspired us to really emphasise the job that we do, help the community and help out the fellow citizens in our home town and really try and protect as many people as we can.”

Praising the initiative, Dr Nikki Kanani, GP and deputy lead for the NHS Covid vaccination programme, said: “We continue to see incredible progress in the NHS Covid vaccination programme, with people still coming forward every day for their first dose, their second dose, their booster dose, and I am really proud of all our teams who are still being so creative, trying to make sure that the vaccine reaches the people who really need it.

“One of our fantastic initiatives over the last couple of weeks has been at V’s Punjabi Grill, where brothers who are pharmacists and also run a grill restaurant have set up shot outside of their restaurant, offering food alongside their vaccinations.

“So they’re just trying to be as creative as possible making sure that people get that life-saving protection.”

Last week, prime minister Boris Johnson informed the House of Commons that more than 36 million Covid-19 booster jabs had been delivered, with over 90 percent of over-60s now given a third dose.

Alongside this information, Johnson announced the lifting of most Covid-19 restrictions in England from January 27.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less